Sunday, February 12, 2012
 
 
  Home arrow Birth Control arrow Sterilization arrow Migraine - Oral Contraceptive Link (N, 06)
Main Menu
Home
About Us
Current Headlines
Abortion
Abstinence
Birth Control
End of Life / Euthanasia
Medical Research
Medical Students
Population
Position Statements
Pregnancy/Development
STDs
Stem Cells & Cloning
Contact Us
Web Links
Site Index
Resources
Related Items
Translator
Quotes to Note

It's not the FUNDS that are Lacking for Embryonic Stem Cell Research.

It's the Results.

 

Successful human trials/treatments using Embryonic Stem Cells: 0
Successful human trials/treatments/cures using Adult Stem Cells: 72
 
FDA approved human trials using embryonic stem cells -- 0  [1 in 2009]
FDA approved clinical trials using adult stem cells -- 1,181
 
Embryonic stem cells have been used in ANIMAL trials for 25 years.

After 25 years, and many thousands of dead mice and rats, ESCs have not been shown safe enough for trials in humans, mainly because of their propensity to form tumors (grow uncontrollably), and because of their rejection problems.


[Life Insight, June-July 2006]

 
Migraine - Oral Contraceptive Link (N, 06) PDF Print E-mail

STUDY FINDS ORAL CONTRACEPTIVE-MIGRAINE LINK

Women who take oral contraceptives [OCs] have increased chances of suffering from both migraines and non-migraine headaches, a large new population-based study shows.

Some women have migraines during menstruation, when levels of estrogen drop, said Dr. Karen Aegidius [Norwegian National Headache Center, Trondheim, the study‘s lead author]. These women also are more likely to have migraines while taking OCs; these pills can boost estrogen levels up to four-fold above normal, resulting in a particularly steep estrogen drop-off with menstruation.

Aegidius and her colleagues studied data from 13,944 women included in the Nord-Trondelag Health Study in Norway who responded to questions on both OC use and headaches.

Migraines were 40 percent more common among women taking OCs, the researchers report in the medical journal Neurology, and non-migraine headaches were 20 percent more common. However, the team could find no link between the amount of hormones contained in the pills and headache risk.

Physicians whose patients suffer headaches while on the pill could prescribe an estrogen patch to be used 2 to 3 days before menstruation, Aegidius suggested, so that estrogen levels wouldn‘t drop so steeply.

Another possibility, she added, is for women to stay on estrogen for 3 consecutive months, so they experience headaches just 4 times a year rather than every month.


Finally, she pointed out that the fall in estrogen with Mircette, an OC available in the US but not Europe, is gradual rather than immediate, which could reduce headache risk.

[Neurology, 14Feb06; posted 4 March06, Anne Harding 2Mar06 New York, Reuters Health;  N Valko RN, 5Mar06; http://www.newsone.ca/piercelandherald/stories/index.php?action=fullnews&id=152680]

 
< Prev   Next >


Go to top of page  Home | About Us | Current Headlines | Abortion | Abstinence | Birth Control | End of Life / Euthanasia | Medical Research | Medical Students | Population | Position Statements | Pregnancy/Development | STDs | Stem Cells & Cloning | Contact Us | Web Links | Site Index | Resources |
 
PhysiciansForLife.org Copyright (C) 2004-2012 All Rights Reserved